KORU Medical Systems Inc (NAS:KRMD)

Q4 2024 KORU Medical Systems Inc Earnings Call Transcript

Mar 12, 2025 / 08:30 PM GMT

Release Date Price: $3.28 (+5.47%)

Transcript 10-K8-K

Key Points

Positve

KORU Medical Systems Inc (KRMD) achieved record-setting revenues in the fourth quarter, with a 23% increase, and full-year revenues grew by 18%.
The company expanded its gross margins, achieving a record-setting gross profit for the full year 2024.
KORU Medical Systems Inc (KRMD) successfully entered multiple new international geographies, contributing to a 32% growth in international revenues.
The company added four new collaborations to its novel therapies pipeline in 2024, with two more announced in early 2025.
KORU Medical Systems Inc (KRMD) maintained a strong cash position, ending the year with a cash balance of $9.6 million, exceeding expectations.

Negative

The novel therapies segment is subject to revenue lumpiness, which could impact overall financial performance.
The company faces potential challenges from tariffs, although the impact is expected to be minimal.
There is a dependency on the immunoglobulin market, which currently accounts for 90% of total revenues.
The FDA's announcement regarding the voluntary withdrawal of certain immunoglobulin lots could pose a short-term risk.
The company's guidance for 2025 indicates a deceleration in revenue growth compared to 2024.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KRMD.OQ - KORU Medical Systems Inc
Q4 2024 KORU Medical Systems Inc Earnings Call
Mar 12, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the core of Medical Systems 4th quarter in full year 2024 financial results conference call and webcast. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded.

I would now like to turn the conference over to Louisa Smith of Gil Martin Group. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Julian, and good afternoon, everyone. Joining me on the call today are Linda Tharby, President and CEO of

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.